Isoform-selective phosphoinositide 3′-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell–mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approachMatthias Niedermeier, Jan A. Burger, Zachary A. Knight et al.|Blood|2009Cited by 143